Bjorn Knollmann

June 8, 2023

Targeting calcium handling in A-fib

The drug ent-verticilide reduced A-fib incidence and duration in an animal model, suggesting it may be a viable therapeutic option.

By Leigh MacMillan
May 31, 2023

Four from VUMC receive Heart Rhythm Society awards

Four physician-scientists from Vanderbilt University Medical Center won awards during the Heart Rhythm Society’s annual meeting.

By Matt Batcheldor
February 2, 2022

VUMC’s Knollman, Ware among new AAAS Fellows

Vanderbilt’s Ware, Knollman among new American Association for the Advancement of Science Fellows.

By Kathy Whitney
June 14, 2018

VUMC joins research network to fight atrial fibrillation

Vanderbilt University Medical Center (VUMC) has been selected by the American Heart Association (AHA) to participate in a six-member research network to advance treatment and prevention of atrial fibrillation (AFib), an irregular heart rate that increases the risk of stroke and other heart-related complications.

By Bill Snyder
May 3, 2018

Six Vanderbilt physicians honored by medical societies

Four faculty members of Vanderbilt University School of Medicine were among 78 physician-scientists inducted into The American Society for Clinical Investigation (ASCI), an elite honor society of physician-scientists from the upper ranks of academic medicine and industry. They are:

By Bill Snyder
L-r: Eric Johnson, Björn Knollmann, Dai Chung, Dan Roden, Russell Rothman, Susan Wente, Carrie Kitko, Dane Chetkovich, Rangaraj Ramanujam, Timothy Vogus, Berk Sensoy and Jeff Balser. (John Russell/Vanderbilt)
March 5, 2018

Nine new endowed chair recipients honored

Nine Vanderbilt University faculty members named to endowed chairs were honored during a celebration at the Student Life Center Feb. 28.

By VUMC News and Communications
January 14, 2016

Knollmann to direct new arrhythmia research center

Björn Knollmann, M.D., Ph.D., has been named director of the newly formed Vanderbilt Center for Arrhythmia Research and Therapeutics (VanCART).
By Kathy Whitney
January 14, 2016

New method aids heart disease studies, drug discovery efforts

A team of Vanderbilt investigators developed a new method for rapidly generating heart muscle cells from stem cells.
By Leigh MacMillan
May 12, 2014

Normalizing calcium flux to treat atrial fibrillation

A particular anti-arrhythmia drug provides a targeted treatment for certain forms of atrial fibrillation.
By Leigh MacMillan
July 26, 2013

Reducing fatal rhythms after heart attack

Reducing heart muscle response to calcium could decrease the risk of fatal arrhythmias after heart attacks.
By Courtney M. Campbell
November 16, 2012

Green tea for failing hearts?

The main antioxidant compound in green tea increases contractile force in isolated heart cells, suggesting it may be useful in heart failure.
By Leigh MacMillan